Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells
A. Boots (Maastricht, Netherlands), C. Veith (Maastricht, Netherlands), M. Kreuter (Heidelberg, Germany), M. Schneider (Heidelberg, Germany), M. Meister (Heidelberg, Germany), A. Smolinska (Maastricht, Netherlands), F. Van Schooten (Maastricht, Netherlands), N. Kahn (Heidelberg, Germany)
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Session: Cellular stress in respiratory diseases
Session type: E-poster session
Number: 605
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Boots (Maastricht, Netherlands), C. Veith (Maastricht, Netherlands), M. Kreuter (Heidelberg, Germany), M. Schneider (Heidelberg, Germany), M. Meister (Heidelberg, Germany), A. Smolinska (Maastricht, Netherlands), F. Van Schooten (Maastricht, Netherlands), N. Kahn (Heidelberg, Germany). Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells. 605
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
The impact of idiopathic pulmonary fibrosis on the airway length per generation in the human lung Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021
Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 334s Year: 2005
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers and healthy controls Source: Eur Respir J 2001; 18: Suppl. 33, 520s Year: 2001
The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Characterization of in vitro differentiated bronchial epithelial cells obtained from patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 99s Year: 2004
Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013
Differential response of COPD bronchial epithelium to LPS in a three-dimensional culture model Source: Annual Congress 2006 - Airway epithelial cells in inflammation Year: 2006
Apoptosis in epithelial cells in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 481s Year: 2004
Decreasing of lung function in patients with chronically obstructive lung diseases as effect of damage of bronchial mucosa cilia Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2004; 24: Suppl. 48, 61s Year: 2004
Monocyte subpopulations, airway inflammation and lung function in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols containing nanoparticles Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020
The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 307s Year: 2004
Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care Source: Eur Respir J 2008; 32: 945-952 Year: 2008
Cultivating bronchial epithelial cells collected through bronchoscopic microsampling in patients with interstitial lung disease Source: International Congress 2016 – ILD pathogenesis Year: 2016